A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study

MeSH terms

• Adult
• Aged
• Antineoplastic Agents, Alkylating / therapeutic use
• Combined Modality Therapy
• Febrile Neutropenia / etiology
• Female
• Home Care Services*
• Humans
• Male
• Melphalan / adverse effects
• Melphalan / therapeutic use
• Middle Aged
• Multiple Myeloma / therapy*
• Non-Randomized Controlled Trials as Topic
• Outpatients*
• Prospective Studies
• Stem Cell Transplantation / adverse effects
• Stem Cell Transplantation / methods*
• Transplantation, Autologous
• Treatment Outcome